Table 2.
Factors associated with disclosure to steady partner/spouse and disclosure to at least one confidant in the social network (immediate and extended family, friends, priests, folk healer): univariate and multivariate analyses. ANRS-EN13-VESPA Study
| Steady partner/spouse
|
Social network
|
|||||
|---|---|---|---|---|---|---|
| Univariate | Multivariate | Univariate | Multivariate | |||
| na (%b) disclosed | p-value | OR (95% CI) | na (%b) disclosed | p-value | OR (95% CI) | |
| 173 (84.6) | 398 (55.6) | |||||
| Territory | ||||||
| St Martin | 13 (87.1) | 2.20 (0.12–39.60) | 30 (66.7) | 2.69 (1.02–7.05)* | ||
| Guadeloupe | 49 (85.1) | 1 | 138 (56.6) | 1 | ||
| Martinique | 46 (91.6) | 1.46 (0.38–5.56) | 91 (63.2) | 0.96 (0.53–1.75) | ||
| French Guiana | 65 (78.8) | 0.35 | 2.09 (0.45–9.62) | 139 (47.1) | 0.08 | 0.83 (0.45–1.51) |
| Gender | ||||||
| Male | 88 (86.7) | 1 | 209 (52.3) | 1 | ||
| Female | 85 (82.5) | 0.43 | 0.59 (0.22–1.60) | 189 (59.1) | 0.18 | 2.04 (1.24–3.36)** |
| Age at diagnosis | ||||||
| <30 | 61 (88.9) | 1 | 108 (65.8) | 1 | ||
| 30–39 | 59 (85.1) | 0.49 (0.16–1.52) | 133 (57.2) | 0.77 (0.43–1 .38) | ||
| 40–49 | 33 (82.8) | 0.75 (0.22–2.63) | 92 (54.3) | 1.11 (0.57–2.14) | ||
| >=50 | 20 (73.1) | 0.39 | 0.23 (0.04–1.27)† | 65 (36.4) | 0.003 | 0.42 (0.19–0.90)* |
| Nationality | ||||||
| French | 102 (92.4) | 1 | 227 (62.3) | 1 | ||
| Haitian | 44 (71.5) | 0.11 (0.02–0.72)* | 114 (38.1) | 0.39 (0.19–0.77)** | ||
| Other | 27 (70.2) | 0.001 | 0.13 (0.02–0.68)* | 57 (61.6) | 0.15 | 0.92 (0.44–1.93) |
| Education | ||||||
| None or primary school | 52 (77.5) | 0.59 (0.12–3.04) | 157 (40.3) | 0.49 (0.24–1.01)† | ||
| Secondary school | 82 (84.2) | 0.28 (0.08–1.01)† | 161 (62.9) | 0.90 (0.49–1.66) | ||
| High school or more | 39 (93.0) | 0.21 | 1 | 80 (68.3) | <0.001 | 1 |
| Date of HIV diagnosis | ||||||
| <= 1996 | 76 (95.1) | 1 | 180 (59.6) | 1 | ||
| >1996 | 97 (76.4) | 0.002 | 0.21 (0.05–0.86)* | 218 (52.3) | 0.15 | 1.03 (0.63–1.69) |
| Mode of HIV acquisition | ||||||
| Male-to-male | 20 (90.1) | 52 (63.9) | 1.49 (0 .73–3.03) | |||
| Heterosexual | 144 (82.9) | 324 (52.5) | 1 | |||
| Other | 9 (100) | 0.39 | 22 (80.1) | 0.03 | 3.38 (1.12–10.23)* | |
| CDC Stage C | ||||||
| No | 130 (83.7) | 1 | 286 (53.6) | 1 | ||
| Yes | 43 (88.1) | 0.12 | 1.00 (0.35–2.89) | 112 (61.3) | 0.16 | 1.45 (0.86–2.45) |
| Hospitalisation since diagnosis | ||||||
| No | 40 (91.5) | 2.03 (0.54–7.69) | 105 (65.9) | 1 | ||
| Yes | 133 (82.9) | 0.45 | 1 | 293 (52.5) | 0.02 | 1.98 (1.17–3.37)* |
a
Observed number
b
weighted %
**
p<0.01
*
p<0.05
†
p≤0.10